Fig. 2From: Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumabImprovement in patients following etanercept, adalimumab or tocilizumab treatment according to Juvenile Disease Activity Score (JADAS)10 at baseline compared with the last observation on a study drugBack to article page